Literature DB >> 15138395

[Indoor radon exposure and lung cancer risk: a review of case-control studies].

H Baysson1, M Tirmarche.   

Abstract

BACKGROUND: Radon is a radioactive gas that tends to accumulate in indoor environment. A causal relationship between lung cancer and radon exposure has been demonstrated in epidemiologic studies of miners. The objective of this paper is to present the results of case-control studies of lung cancer risk associated with indoor radon exposure.
METHODS: Case-control studies published since 1990 are included in this review. This type of protocol is particularly well suited for studying the relationship between indoor radon exposure and lung cancer risk, taking into account possible confounding factors such as tobacco smoking. The characteristics and results of these studies are summarized. The limitations associated with each of these studies are also discussed.
RESULTS: The results of available studies are relatively concordant and suggest a positive association between lung cancer risk and indoor radon exposure with an estimated excess relative risk of about 6 to 9% per 100Bq/m3 increase in the observed time-weighted average radon concentration. The order of magnitude of this estimation agrees with extrapolations from miners but some studies may suffer from inadequate statistical power.
CONCLUSION: At present, efforts are underway to pool together the data from the existing studies of indoor radon. This pooling analysis with thousands of cases and controls will provide a more precise estimate of the lung cancer risk from indoor radon exposure and explore the effect of modifying factors, such as smoking.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15138395     DOI: 10.1016/s0398-7620(04)99037-2

Source DB:  PubMed          Journal:  Rev Epidemiol Sante Publique        ISSN: 0398-7620            Impact factor:   1.019


  1 in total

1.  Radon Exposure-induced Genetic Variations in Lung Cancers among Never Smokers.

Authors:  Jung Ran Choi; Sang Baek Koh; Hye Ryun Kim; Hyojin Lee; Dae Ryong Kang
Journal:  J Korean Med Sci       Date:  2018-06-20       Impact factor: 2.153

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.